Next-Generation Sequencing (NGS) is increasingly being used for HLA typing. Several NSG-based protocols have recently been developed by various companies by building their respective NGS platforms. The report “Global Transplant Diagnostic Market (HLA Typing - Molecular Assays and Non-Molecular Assays; Product Type - Reagents & Consumables, Instruments & Software & Services) Market Outlook 2024” provides information on the current scenario, market outlook of the global transplant diagnostic. The market is segmented along types of HLA Typing and Product type. Detailed analysis of these segments is provided in the report. The market is further analyzed with the detailed market outlook for global as well as regional markets such as North America, Europe, and the Asia Pacific. Market outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market-specific growth opportunities in the global transplant diagnostic market. The report has been segmented as follows:-
- HLA Typing - Molecular Assays & Non-Molecular Assays
- Product Type - Reagents & Consumables, Instruments & Software & Services
- North America - The US
- Europe - Italy
- Asia Pacific
- Thermo Fisher Scientific Inc.
- F.Hoffman-La Roche Ltd.,
- Abbott Laboratories Inc.
- Qiagen N.V.
- Immucor Inc.
Transplantation refers to the process of replacing damaged or missing organs from the donor site. In order to determine tissue compatibility between potential donor and recipient, Human leukocyte diagnostic (HLA) testing is performed. Human leukocyte antigens are basically histocompatibility complex found on the cell surface that are used as markers by the immune system to recognize cells which belongs to the body. HLA typing maximizes the chances of graft survival while minimizing serious immunologic transplant complications. These tests are performed using various assays- Molecular assays (Serology and Mixed Lymphocyte Culture (MLC) and Non-molecular assays (Polymerase Chain Reaction and Next Generation Sequencing).
Global transplant diagnostic market is driven by rising demand for organ transplants, increasing geriatric population, prevalence of chronic diseases and various favorable government initiatives. However, factors such as organ shortage for transplant, limited medical reimbursement, lack of awareness and stringent regulatory norms are restraining growth of the market.
The report “Global Transplant Diagnostic Market (HLA Typing - Molecular Assays and Non-Molecular Assays; Product Type - Reagents & Consumables, Instruments & Software & Services) Market Outlook 2024” provides information on the current scenario, market outlook of the global transplant diagnostic. The market is segmented along types of HLA Typing and Product type. Detailed analysis of these segments are provided in the report. Geographically, the market is segment along North America, Europe and Asia Pacific region. Future forecasts of transplant diagnostic market overall and across various sub-segments has been provided till 2024, for all the geographies. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global transplant diagnostic market includes Thermo Fisher Scientific Inc., F.Hoffman-La Roche Ltd., Abbott Laboratories Inc., Qiagen N.V., Immucor Inc., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as regional transplant diagnostic market.
1. Executive Summary
2. Research Methodology
3. Transplant Diagnostic
3.2 Organ Transplant
3.3 HLA Typing
126.96.36.199 Mixed Lymphocyte Culture (MLC)
188.8.131.52 Polymerase Chain Reaction (PCR)
184.108.40.206 Sequencing Based
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Product Type
4.2.2 Market Share by Technology
4.2.3 Market Share by Type of Organ
4.2.4 Market Share by Region
5. Market Segmentation
5.1 HLA Typing
5.1.1 Molecular Assays
5.1.2 Non-Molecular Assays
5.2 Product Type
5.2.1 Reagents & Consumables
5.2.3 Software & Services
6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.2.1 Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trend & Development
7.1.1 Next Generation Sequencing for HLA Typing
7.1.2 Recent Deals
7.1.3 Other Technological Advancements
7.2 Growth Drivers
7.2.1 Rising Demand for Organ Transplants
7.2.2 Increasing Geriatric Population
7.2.3 Prevalence of Chronic Diseases
7.2.4 Government Initiatives
7.3.1 Organ Shortage for Transplant
7.3.2 Limited Medical Reimbursement
7.3.3 Lack of Awareness
7.3.5 Stringent Regulations
8. Competitive Landscape
9. Company Profiles
9.1 Thermo Fisher Scientific Inc.
9.2 F. Hoffman-La Roche Ltd.
9.3 Abbott Laboratories Inc.
9.4 Qiagen N.V.
9.5 Immucor Inc.